Report timing: Camden is scheduled to release 2Q26 results after the market close on Thursday, July 30, 2026. Its earnings call is scheduled for Friday, July 31 at 10:00 a.m. Central Time.
CPT enters earnings with a relatively clear near-term setup: results should be judged less on the headline Core FFO number and more on evidence that Sunbelt apartment fundamentals are inflecting as supply pressure recedes. Management’s June operating update said 2Q trends remained in line with the company’s prior outlook, which lowers the odds of a major operational surprise. The more important question is whether July leasing data validates management’s expectation for a stronger 3Q and an atypically healthy 4Q.
The other pivotal issue is capital allocation. Investors will want an explicit update on the proposed sale of 11 California communities and the associated redeployment program—acquisitions, 1031 exchanges, potential buybacks, leverage, and any risk of taxable gains/special distributions. The transaction has the potential to reshape CPT’s market mix and near-term earnings cadence.
For 2Q26, CPT guided to:
| Metric | 2Q26 guidance |
|---|---|
| EPS | $0.13–$0.17 |
| FFO per share | $1.63–$1.67 |
| Core FFO per share | $1.65–$1.69 |
The $1.67 Core FFO midpoint implies a modest decline from 1Q26 Core FFO of $1.70 per share. Management attributed the expected sequential decline primarily to seasonally higher repairs and maintenance expense and the timing of annual merit increases, partially offset by incremental NOI from net acquisitions.
For the full year, CPT maintained its Core FFO guidance midpoint of $6.75 per share, alongside same-property guidance of:
That full-year outlook assumes improving lease spreads through the core leasing season and continued absorption of excess apartment supply.
CPT’s 1Q26 underlying operations were still soft, but trends had begun to improve:
Importantly, management said April occupancy improved to roughly 95.4%, while blended rent growth improved by about 100 basis points versus 1Q. Renewal offers for May through July were being sent at increases in the mid-3% range.
This quarter needs to show that the April improvement was not simply seasonal. The best evidence would be:
Management previously highlighted Atlanta, Dallas, Orlando, Nashville, Raleigh, and Southeast Florida as early “green shoot” markets. These markets matter because they should be among the earliest beneficiaries of lower deliveries and are central to CPT’s Sunbelt-oriented strategy.
Houston remains the principal watch item. CPT characterized its Houston issue as more sentiment-driven than a structural demand problem: job and population growth remain favorable and resident rent-to-income is low, but leasing results and occupancy had lagged. A stabilizing Houston commentary would strengthen the recovery narrative; further weakness would challenge it.
CPT’s thesis is that this is predominantly a supply absorption story, rather than a demand shortfall. Management previously cited apartment completions across its markets falling from approximately 200,000 in 2025 to roughly 140,000–150,000 in 2026, with further reductions expected thereafter.
That backdrop makes the following language especially important on the call:
A reaffirmation of the “strong 3Q / better 4Q” setup would likely matter more to the stock than a modest Core FFO beat.
CPT had been marketing 11 California operating communities for sale. At the 1Q call, management said it was in diligence with a single buyer for the full portfolio, targeting a close around late June or early July, while noting other buyers could step in if needed.
That makes the transaction-status update central to 2Q results.
Did the California sale close?
If not, why not, and what is the updated expected timing and execution risk?
What were the proceeds, implied cap rate, and gain?
These determine the scale of redeployment, the potential taxable-income impact, and the quality of the value realization.
How much has been committed to acquisitions?
CPT previously said it had awarded roughly $250 million of additional acquisitions on top of the approximately $171 million of Atlanta and Orlando acquisitions completed after 1Q. It had targeted about $1 billion of acquisitions to facilitate 1031 exchange treatment.
Will buybacks resume?
CPT repurchased approximately $423 million of stock through April at an average price of $104.08 per share. It had $297.8 million of remaining authorization after those repurchases, although its full-year guidance assumed no additional buybacks. With the shares at $116.18 at the July 29 close—up about 10.6% from the April 30 close—the return hurdle for incremental repurchases is higher than it was earlier in the year.
What is the earnings impact of transaction timing?
CPT has already warned that the timing of California sale proceeds and reinvestment can create meaningful variability in 2026 earnings. Investors should distinguish any timing-related FFO movement from changes in core leasing fundamentals.
CPT ended 1Q with approximately:
During 1Q, CPT issued $600 million of 10-year unsecured notes with a 4.90% coupon and approximately 5.03% effective interest rate, while extending its $1.2 billion revolving-credit facility to March 2030.
The balance sheet supports CPT’s acquisition and buyback optionality, but investors should focus on whether 2Q activity has changed:
In 1Q, CPT recorded a $53 million proposed class-action settlement related to rental-revenue-management software litigation, plus other related legal costs. The charge was excluded from Core FFO, which is why Core FFO remains the appropriate earnings measure for evaluating operating performance.
Still, the matter is not entirely behind the company: the settlement remained subject to finalization and court approval, while other governmental and related legal proceedings were ongoing. Investors should look for confirmation that the expected cash payments, prospective commitments, and legal costs remain consistent with prior disclosures.
CPT is transitioning from a period of supply-driven operating pressure toward what management expects will be a multi-year Sunbelt recovery. The company’s 2Q guidance is not demanding, and the June update indicates it was tracking to plan. Therefore, the true test is forward-looking:
Does CPT provide enough July leasing evidence to make its 3Q/4Q recovery outlook credible, while simultaneously demonstrating disciplined execution on the California disposition and capital redeployment plan?
A routine in-line quarter with convincing leasing and transaction updates could be constructive. Conversely, a technically in-line print accompanied by delayed asset-sale timing, a softer July trend, or a less confident recovery cadence would likely outweigh a small Core FFO beat.